Aspirin Use and Risk of Fatal Cancer

15 Mar 1993Michael J. Thun, Mohan M. Namboodiri, Eugenia E. Calle, W. Dana Flanders and Clark W. Heath Jr.

Data suggest that regular, prolonged use of aspirin may reduce the risk of fatal cancer of the esophagus, stomach, colon, and rectum.

Meta Analysis
4 effects
1982 to 1988
635031 subjects

Reported Outcomes

CausesOutcomeCertainty

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Lung cancer Respiratory outcome
Decreased risk of Lung cancer
Respiratory system

Evidence: Very High
-40.0%

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Oesophagus cancer Digestive outcome
Decreased risk of Oesophagus cancer
Digestive system

Evidence: Very High
-40.0%

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Stomach cancer (Gastric cancer) Digestive outcome
Decreased risk of Stomach cancer (Gastric...
Digestive system

Evidence: Very High
-40.0%

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Colorectal Cancer Digestive outcome
Decreased risk of Colorectal Cancer
Digestive system

Evidence: Very High
-40.0%